Connecting people to processes and systems is characteristic of most industries nowadays, but there’s no sector where this is more evident than mHealth.
Mobile ‘eco-systems’ will enable our society to explore new approaches towards tackling chronic illness and smartphone technology has a huge role to play in this revolutionary approach to healthcare.
Leading smartphone diagnostics specialist Novarum® DX is operating at the vanguard of this new landscape. Since 2012, Novarum has developed innovative camera-based smartphone technology that enables the results of diagnostic tests to be read accurately from the point of care. An intuitive mobile app allows patients to send these test results to an online web portal, accessible by healthcare professionals.
Novarum’s approach presents new avenues for patient care through provision of lab-quality results, using nothing more than a smartphone. The portal enables data to be shared safely and securely between patients and physicians, including knowledge partners, working to unlock behavioral patterns found in chronic disease.
Novarum was acquired by BBI Group® in October 2016 to form an end-to-end solution for the company’s lateral flow services offered by BBI Solutions. Dr Neil Polwart, Founder of Novarum DX and BBI Group Head of Mobile, said: “Smartphone enabled medical eco-systems empower patients to manage their conditions in a connected environment and have real potential to transform the way we approach diagnosis and treatment. Devices which empower patients to manage chronic disease can supply healthcare professionals with a patient’s data trail to support research, trend analysis, expedite early diagnosis and improve treatment”.
“Healthcare is rapidly moving away from a scenario where diagnostic testing could only be carried out in a highly controlled and regulated environment. We are now entering a landscape where patients can conduct their diagnostic tests outside laboratory conditions, and share results instantly with healthcare professionals and selected knowledge partners – using only the smartphone in their pocket.”
One leading organisation that has worked closely with Novarum to develop a new connected approach is world-leading in-vitro diagnostic specialist, BÜHLMANN Laboratories AG, based in Switzerland. Producers of unique, high-quality assays for routine clinical use, BÜHLMANN’s calprotectin assays are paving the way for inflammatory bowel disease (IBD) screening as well as disease monitoring…
Read the full article (PDF) >>
